Clinical Trial Detail

NCT ID NCT01640301
Title Laboratory-Treated T Cells in Treating Patients With High-Risk Relapsed Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelogenous Leukemia Previously Treated With Donor Stem Cell Transplant
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Fred Hutchinson Cancer Research Center
Indications

bone marrow cancer

acute myeloid leukemia

chronic myeloid leukemia

Therapies

Aldesleukin

WT1 sensitized T cells

Age Groups: senior adult child

No variant requirements are available.